Assessment of Right Ventricular Function After Acute Pulmonary Embolism Using Speckle Tracking Echocardiography

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04609605

Enrollment

Registered

2020-10-30

Start date

2020-12-31

Completion date

2022-01-31

Last updated

2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Embolism

Brief summary

1. To asses regional RV function in patients presented with acute pulmonary embolism using speckle tracking echocardiography 2. To evaluate its relationship to long term mortality.

Detailed description

Pulmonary embolism (PE) is the third most common cardiovascular cause of death after myocardial infarction and stroke . The incidence of PE has been increasing ,with significant associated mortality; a recent registry of PE patients reported a mortality rate \> 10% at 30 days. There are a number of emerging contemporary PE therapies, including thrombolysis, catheter intervention and surgery. Early and accurate identification of PE in patients is therefore critical. A transthoracic echocardiogram (TTE) may help when there is a clinical suspicion for PE, and its use in confirmed PE is widely recommended . A number of right atrial (RA) and right ventricular (RV) parameters have been shown to be abnormal in patients with PE . In addition, RA and RV enlargement portends a worse prognosis in these patients .

Interventions

DEVICEspeckle tracking echocardiography

speckle tracking echocardiography of right ventricle

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

20 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

1. clinical diagnosis of acute pulmonary embolism 2. Age: 20 - 70 years.

Exclusion criteria

1. coronary artery disease 2. patient of Atrial fibrillation. 3. Patient of impaired RV function due to chest disease (Cor-pulmonale) 4. patient with impaired Ejection fraction (EF) \<50% 5. Moderate to severe valvular heart disease. 6. Atrio-ventricular conduction disturbance. 7. Poor echogenicity

Design outcomes

Primary

Measure	Time frame	Description
improve management of acute pulmonary embolism	baseline	comparison between speckle tracking echocardiograpgy and conventional echocardiography in pulmonary embolism

Contacts

Primary ContactMahmoud Said rashwan, master degree of cardiology

dr.ma7moudsaid@gmail.com01007949203

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026